Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

830390

registered interest
date	25/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Greater London
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps the new provider of Central and East London breast screening services has taken to ensure that those services will be maintained in their current locations.
tabling member constituency	East Ham
tabling member printed	Stephen Timms
uin	124956
answer	answer is ministerial correction date of answer 30/01/2018 answer text <p>Neither NHS England nor NHS Improvement has provided information specifically in relation to the locations to be used under the new contract.</p><p> </p><p>Data from the Breast Screening Programme, England – 2015/16 (NHS Digital) shows that the proportion of people who took up the invitation to attend breast screening services by Central East London Breast Screening Service (CELBSS) was 61.0%, compared to 64.9% for London and 72.1% nationally. NHS England also advises that provisional data for the first quarter of 2017/18 shows that 3,267 (50.1%) of 6,515 invited by CELBSS have attended.</p><p> </p><p>Further information regarding the proportion of people invited to breast screening by Central and East London breast screening services is available on the Public Health England website at the following link:</p><p> </p><p><a href="https://fingertips.phe.org.uk/profile/public-health-outcomes-framework/data#page/3/gid/1000049/pat/6/par/E12000007/ati/102/are/E09000002/iid/90362/age/1/sex/1" target="_blank">https://fingertips.phe.org.uk/profile/public-health-outcomes-framework/data#page/3/gid/1000049/pat/6/par/E12000007/ati/102/are/E09000002/iid/90362/age/1/sex/1</a></p><p> </p><p>NHS England advises that the new contract has yet to be finalised, however the Royal Free will be expected to provide a service and perform in line with the national standards for breast screening set out in the national service specification.</p><p> </p><p>Barts Health NHS Trust, the current service provider, advises that it has been working closely with the Royal Free to ensure an orderly transition, so that patients continue to receive high quality and timely care under the new arrangements. At the same time, Barts is focussing on keeping staff informed and reassured about their own future.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 124957 124958 question first answered 30/01/2018 17:12:25 answering member 4067 label Biography information for Steve Brine
tabling member	163 label Biography information for Sir Stephen Timms

830391

registered interest
date	25/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Greater London
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what information he holds on the proportion of people invited to breast screening by Central and East London breast screening services who have taken up that invitation in the last 12 months for which data is available.
tabling member constituency	East Ham
tabling member printed	Stephen Timms
uin	124957
answer	answer is ministerial correction date of answer 30/01/2018 answer text <p>Neither NHS England nor NHS Improvement has provided information specifically in relation to the locations to be used under the new contract.</p><p> </p><p>Data from the Breast Screening Programme, England – 2015/16 (NHS Digital) shows that the proportion of people who took up the invitation to attend breast screening services by Central East London Breast Screening Service (CELBSS) was 61.0%, compared to 64.9% for London and 72.1% nationally. NHS England also advises that provisional data for the first quarter of 2017/18 shows that 3,267 (50.1%) of 6,515 invited by CELBSS have attended.</p><p> </p><p>Further information regarding the proportion of people invited to breast screening by Central and East London breast screening services is available on the Public Health England website at the following link:</p><p> </p><p><a href="https://fingertips.phe.org.uk/profile/public-health-outcomes-framework/data#page/3/gid/1000049/pat/6/par/E12000007/ati/102/are/E09000002/iid/90362/age/1/sex/1" target="_blank">https://fingertips.phe.org.uk/profile/public-health-outcomes-framework/data#page/3/gid/1000049/pat/6/par/E12000007/ati/102/are/E09000002/iid/90362/age/1/sex/1</a></p><p> </p><p>NHS England advises that the new contract has yet to be finalised, however the Royal Free will be expected to provide a service and perform in line with the national standards for breast screening set out in the national service specification.</p><p> </p><p>Barts Health NHS Trust, the current service provider, advises that it has been working closely with the Royal Free to ensure an orderly transition, so that patients continue to receive high quality and timely care under the new arrangements. At the same time, Barts is focussing on keeping staff informed and reassured about their own future.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 124956 124958 question first answered 30/01/2018 17:12:25 answering member 4067 label Biography information for Steve Brine
tabling member	163 label Biography information for Sir Stephen Timms

830392

registered interest
date	25/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Greater London
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what performance targets have been set in the new contract for Central and East London breast screening services.
tabling member constituency	East Ham
tabling member printed	Stephen Timms
uin	124958
answer	answer is ministerial correction date of answer 30/01/2018 answer text <p>Neither NHS England nor NHS Improvement has provided information specifically in relation to the locations to be used under the new contract.</p><p> </p><p>Data from the Breast Screening Programme, England – 2015/16 (NHS Digital) shows that the proportion of people who took up the invitation to attend breast screening services by Central East London Breast Screening Service (CELBSS) was 61.0%, compared to 64.9% for London and 72.1% nationally. NHS England also advises that provisional data for the first quarter of 2017/18 shows that 3,267 (50.1%) of 6,515 invited by CELBSS have attended.</p><p> </p><p>Further information regarding the proportion of people invited to breast screening by Central and East London breast screening services is available on the Public Health England website at the following link:</p><p> </p><p><a href="https://fingertips.phe.org.uk/profile/public-health-outcomes-framework/data#page/3/gid/1000049/pat/6/par/E12000007/ati/102/are/E09000002/iid/90362/age/1/sex/1" target="_blank">https://fingertips.phe.org.uk/profile/public-health-outcomes-framework/data#page/3/gid/1000049/pat/6/par/E12000007/ati/102/are/E09000002/iid/90362/age/1/sex/1</a></p><p> </p><p>NHS England advises that the new contract has yet to be finalised, however the Royal Free will be expected to provide a service and perform in line with the national standards for breast screening set out in the national service specification.</p><p> </p><p>Barts Health NHS Trust, the current service provider, advises that it has been working closely with the Royal Free to ensure an orderly transition, so that patients continue to receive high quality and timely care under the new arrangements. At the same time, Barts is focussing on keeping staff informed and reassured about their own future.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 124956 124957 question first answered 30/01/2018 17:12:25 answering member 4067 label Biography information for Steve Brine
tabling member	163 label Biography information for Sir Stephen Timms

830424

registered interest
date	25/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sexually Transmitted Infections: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what duties online sexually transmitted infection testing services have to follow best practice in respect of safeguarding and child protection issues.
tabling member constituency	Lewisham East
tabling member printed	Heidi Alexander
uin	124990
answer	answer is ministerial correction date of answer 30/01/2018 answer text <p>Online sexually transmitted infection services are not offered to under 16s who would be advised to attend their local clinic where a proper safeguarding assessment can be undertaken in person.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/01/2018 12:04:33 answering member 4067 label Biography information for Steve Brine
tabling member	4038 label Biography information for Heidi Alexander

830539

registered interest
date	25/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Liothyronine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate he has made of the money accrued to the public purse in relation to liothyronine under the (a) the voluntary Pharmaceutical Price Regulation Scheme and (b) the statutory scheme; and when those payments were made.
tabling member constituency	Twickenham
tabling member printed	Sir Vince Cable
uin	125067
answer	answer is ministerial correction date of answer 30/01/2018 answer text <p>The costs of branded medicines are controlled by the Pharmaceutical Price Regulation Scheme and the statutory scheme for branded medicines. Liothyronine is an unbranded generic medicine. For unbranded generic medicines, the Department encourages competition between suppliers to keep prices down. In primary care, community pharmacies are incentivised to source products at the lowest possible cost and in secondary care, competitive tenders ensure value-for-money to the National Health Service.</p><p> </p><p>Liothyronine is currently the subject of an investigation by the Competition and Markets Authority, which has provisionally found that the single supplier of the product abused its dominant position to overcharge the NHS by millions for liothyronine tablets. A provisional decision does not necessarily lead to an infringement decision. Where companies have breached competition law, the Department will seek damages and invest that money back into the NHS.</p><p> </p><p>Medicines legislation requires that only medicines licensed for use in the United Kingdom can be marketed in the UK.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 125070 question first answered 30/01/2018 17:14:17 answering member 4067 label Biography information for Steve Brine
tabling member	207 label Biography information for Sir Vince Cable

830540

registered interest
date	25/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Liothyronine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect on the level of caseloads of consultant endocrinologists as a result of changes to the prescription of liothyronine.
tabling member constituency	Twickenham
tabling member printed	Sir Vince Cable
uin	125068
answer	answer is ministerial correction date of answer 30/01/2018 answer text <p>The Department has made no assessment. It is for local clinical commissioning groups in conjunction with local providers to make decisions on implementing NHS England’s guidance on liothyronine and, as part of their decision making, to determine the resources available to implement any change.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/01/2018 17:10:32 answering member 4067 label Biography information for Steve Brine
tabling member	207 label Biography information for Sir Vince Cable

830542

registered interest
date	25/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Liothyronine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether he plans to reduce the cost of liothyronine by procuring the drug from foreign suppliers; and if he will make a statement.
tabling member constituency	Twickenham
tabling member printed	Sir Vince Cable
uin	125070
answer	answer is ministerial correction date of answer 30/01/2018 answer text <p>The costs of branded medicines are controlled by the Pharmaceutical Price Regulation Scheme and the statutory scheme for branded medicines. Liothyronine is an unbranded generic medicine. For unbranded generic medicines, the Department encourages competition between suppliers to keep prices down. In primary care, community pharmacies are incentivised to source products at the lowest possible cost and in secondary care, competitive tenders ensure value-for-money to the National Health Service.</p><p> </p><p>Liothyronine is currently the subject of an investigation by the Competition and Markets Authority, which has provisionally found that the single supplier of the product abused its dominant position to overcharge the NHS by millions for liothyronine tablets. A provisional decision does not necessarily lead to an infringement decision. Where companies have breached competition law, the Department will seek damages and invest that money back into the NHS.</p><p> </p><p>Medicines legislation requires that only medicines licensed for use in the United Kingdom can be marketed in the UK.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 125067 question first answered 30/01/2018 17:14:17 answering member 4067 label Biography information for Steve Brine
tabling member	207 label Biography information for Sir Vince Cable

829843

registered interest
date	24/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tooth Whitening: Advertising
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what guidance his Department provides to dental practices on the promotion of private tooth-whitening procedures in their surgeries.
tabling member constituency	Heywood and Middleton
tabling member printed	Liz McInnes
uin	124613
answer	answer is ministerial correction date of answer 29/01/2018 answer text <p>Only treatments that are clinically necessary are provided on the National Health Service so tooth whitening can only usually be provided privately. No specific guidance is therefore issued by the Department or NHS England on tooth whitening.</p><p> </p><p>As with any other dental cosmetic procedure practices are able to advertise and offer this service to patients privately. Dentists are required to make clear to patients what treatments are being provided on the NHS and privately and the costs, risks and benefits associated with each.</p><p> </p><p>Dentists’ clinical practice is regulated by the General Dental Council. This includes cosmetic procedures such as tooth whitening as well as treatments that are clinically necessary.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/01/2018 16:57:28 answering member 4067 label Biography information for Steve Brine
tabling member	4342 label Biography information for Liz McInnes

829911

registered interest
date	24/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Transport: Environmental Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the status is of the Health Protection (Ships and Aircraft) Regulations.
tabling member constituency	Belfast East
tabling member printed	Gavin Robinson
uin	124661
answer	answer is ministerial correction date of answer 29/01/2018 answer text <p>Port health in England is regulated by the Public Health (Aircraft) Regulations 1979 and Public Health (Ships) Regulations 1979. The Regulations cover measures such as: notification of possible infection or contamination on board a ship/aircraft; risk assessment of people, including medical examination and/or detention and general powers to provide information.</p><p> </p><p>There are no current plans to amend or replace the regulations.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/01/2018 16:49:21 answering member 4067 label Biography information for Steve Brine
tabling member	4360 label Biography information for Gavin Robinson

830077

registered interest
date	24/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Eyesight: Testing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential effect of introducing a compulsory eyesight test for all children aged under 5 on the number of diagnoses of (a) Amblyopia and (b) other serious eye conditions in childhood.
tabling member constituency	Batley and Spen
tabling member printed	Tracy Brabin
uin	124775
answer	answer is ministerial correction date of answer 29/01/2018 answer text <p>No assessment has been made by the Department on whether introducing a compulsory eyesight test for children aged under five would have an effect on the number of diagnoses of Amblyopia and other serious eye conditions in childhood.</p><p> </p><p>All babies have eye screening at birth and again at about six weeks of age by a general practitioner (GP) or health visitor.</p><p> </p><p>In most parts of England, children are offered a screening test to look for reduced vision in one or both eyes during their first year at school.</p><p> </p><p>In addition all children aged under 16 are eligible for free National Health Service sight tests and parents and carers are encouraged to raise any health concerns, including eye health concerns, with their GP.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/01/2018 16:58:38 answering member 4067 label Biography information for Steve Brine
tabling member	4588 label Biography information for Tracy Brabin